menu
    • menu

    Company profile for Equillium

    NEW Drugs in Dev: 7
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our initial product candidate, EQ001, is a clinical stage first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in effector T cell activity, which drives a number of immuno-inflammatory diseases such as graft versus host disease, asthma, uveitis, colitis, lupus and multiple sclerosis. We believe EQ001 may have broad therapeutic utility and our current ...
    Our initial product candidate, EQ001, is a clinical stage first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in effector T cell activity, which drives a number of immuno-inflammatory diseases such as graft versus host disease, asthma, uveitis, colitis, lupus and multiple sclerosis. We believe EQ001 may have broad therapeutic utility and our current pipeline is focused on developing EQ001 as a best-in-class treatment for multiple severe immuno-inflammatory disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EquilliumUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    601 Gateway Blvd., Suite 1020 South San Francisco, CA 94080
    Telephone
    Telephone
    858 412 5302
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.equilliumbio.com/home/default.aspx
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Equillium Unveils Q1 2026 Financials And Corporate Achievements
    Equillium Unveils Q1 2026 Financials And Corporate Achievements

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3294395/0/en/equillium-reports-first-quarter-2026-financial-results-and-corporate-highlights.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Equillium Issues Inducement Grants Under Nasdaq Rule 5635(c)(4)
    Equillium Issues Inducement Grants Under Nasdaq Rule 5635(c)(4)

    01 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/01/3286233/0/en/equillium-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    01 May 2026
    Share Share
    Equillium to Present Research Posters at IMMUNOLOGY 2026
    Equillium to Present Research Posters at IMMUNOLOGY 2026

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3270096/0/en/Equillium-Announces-Poster-Presentations-at-IMMUNOLOGY2026-the-Annual-Meeting-of-the-American-Association-of-Immunologists.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Equillium Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
    Equillium Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267820/0/en/Equillium-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Equillium Unveils 2025 Financials And Key Updates
    Equillium Unveils 2025 Financials And Key Updates

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262562/0/en/Equillium-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Recent-Corporate-and-Clinical-Highlights.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Equillium To Participate In The 38th Annual Roth Conference
    Equillium To Participate In The 38th Annual Roth Conference

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258158/0/en/Equillium-to-Participate-in-the-38th-Annual-Roth-Conference.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search